CAPHRA urges governments to move past false choices between unregulated access and outright bans. The workable middle ground is legal, tightly regulated adult access that is designed to be enforceable with available resources. A compliance-ready framework keeps youth protection at the center, maintains regulatory control of the market, and supports harm reduction outcomes by providing adults with lower-risk options under strict conditions.
CAPHRA Urges Governments To Regulate Nicotine Pouches, Not Prohibit Them
Selasa 03-02-2026,10:00 WIB
Reporter : Jeffri Ginting
Editor : Jeffri Ginting
Kategori :
Terkait
Rabu 25-02-2026,04:00 WIB
CAPHRA calls out FCTC’s “Myths vs Facts” Campaign that Ignores Real-World THR Success
Selasa 03-02-2026,10:00 WIB
CAPHRA Urges Governments To Regulate Nicotine Pouches, Not Prohibit Them
Kamis 08-01-2026,04:00 WIB
VinFast Mengubah Mobil Listrik Menjadi Bagian dari Kehidupan Sehari-hari di Filipina
Sabtu 25-10-2025,12:09 WIB
Green GSM Dapat Penghargaan E-Mobilitas, Sumbang Kemajuan Transportasi Listrik di Filipina
Rabu 14-05-2025,06:00 WIB
VinFast Gandeng 4 Mitra di Filipina, Perluasan Jaringan Layanan yang Kuat
Terpopuler
Selasa 24-02-2026,19:01 WIB
Simak Kata Wakil Ketua I DPRD Seluma, laporan Dugaan Pencurian Mobil yang Libatkan Anaknya
Selasa 24-02-2026,07:40 WIB
Mantan DPRD Kaur dan Bendahara di Setwan Ditahan, Korupsi Perjalanan Dinas Rp13 Miliar
Selasa 24-02-2026,14:16 WIB
Box MCB di Rumah Dinas Bupati Bengkulu Selatan Terbakar, Sempat Buat heboh
Selasa 24-02-2026,15:26 WIB
Gembong Narkoba “El Mencho” Tewas dalam Operasi Militer, Pacar Jadi Kunci Pengungkapan Lokasi
Selasa 24-02-2026,18:01 WIB
Menaker Desak Perbaikan K3 PT ASL Tuntas Mei 2026
Terkini
Rabu 25-02-2026,06:00 WIB
Remaja Ini Naas, Tersengat Listrik Saat Petik Kelapa Muda
Rabu 25-02-2026,04:00 WIB
CAPHRA calls out FCTC’s “Myths vs Facts” Campaign that Ignores Real-World THR Success
Rabu 25-02-2026,03:00 WIB
Hong Kong Tech Delegation Heading for Market Expansion at Mobile World Congress 2026
Rabu 25-02-2026,01:00 WIB
Triple agonist UBT251 delivers up to 19.7% mean weight loss after 24 weeks in phase 2 trial in China
Rabu 25-02-2026,00:00 WIB